Detalles de la búsqueda
1.
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients.
Br J Haematol
; 138(2): 186-95, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17593025
Resultados
1 -
1
de 1
1
Próxima >
>>